erythrosine has been researched along with hexacyanoferrate iii in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crane, FL; Lawrence, J; MacKellar, WC; Morré, DJ; Morré, DM; Sun, E; Sun, I | 1 |
| Jones, W; Li, X; May, JM; Perriott, L; Qu, ZC; Whitesell, RR | 1 |
| Cobb, CE; Juliao, S; May, JM; Qu, ZC | 1 |
3 other study(ies) available for erythrosine and hexacyanoferrate iii
| Article | Year |
|---|---|
Proton release from HeLa cells and alkalization of cytoplasm induced by diferric transferrin or ferricyanide and its inhibition by the diarylsulfonylurea antitumor drug N-(4-methylphenylsulfonyl)-N'-(4-cholorophenyl) urea (LY181984).
Topics: Amiloride; Antineoplastic Agents; Calibration; Cytoplasm; Drug Interactions; Ferricyanides; Fluoresceins; Fluorescence; Fluorescent Dyes; HeLa Cells; Humans; Hydrogen-Ion Concentration; Kinetics; Protons; Sodium; Stimulation, Chemical; Sulfonylurea Compounds; Transferrin | 1995 |
Uptake, recycling, and antioxidant actions of alpha-lipoic acid in endothelial cells.
Topics: Antioxidants; Ascorbic Acid; Dehydroascorbic Acid; Endothelium, Vascular; Ferricyanides; Fluoresceins; Glucose; Glutathione; Humans; NAD; NADP; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidation-Reduction; Reactive Oxygen Species; Thioctic Acid; Umbilical Veins | 2002 |
Ascorbic acid decreases oxidant stress in endothelial cells caused by the nitroxide tempol.
Topics: Antioxidants; Ascorbic Acid; Cell Line; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Ferricyanides; Fluoresceins; Glutathione; Humans; Oxidation-Reduction; Oxidative Stress; Spin Labels; Time Factors | 2005 |